Barclays’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $52.7M | Buy |
|
|||||
|
2019
Q4 | $7.62M | Buy |
|
|||||
|
2019
Q3 | $455K | Sell |
|
|||||
|
2019
Q2 | $1.5M | Buy |
|
|||||
|
2019
Q1 | $637K | Buy |
|
|||||
|
2018
Q4 | $405K | Sell |
|
|||||
|
2018
Q3 | $502K | Buy |
|
|||||
|
2018
Q2 | $49K | Sell |
|
|||||
|
2018
Q1 | $40K | Buy |
|
|||||
|
2017
Q4 | $51K | Sell |
|
|||||
|
2017
Q3 | $149K | Buy |
|
|||||
|
2017
Q2 | $116K | Buy |
|
|||||
|
2017
Q1 | $72K | Sell |
|
|||||
|
2016
Q4 | $52K | Buy |
|